Rapamycin (Sirolimus) vs SGLT2 Inhibitors (Empagliflozin / Canagliflozin)
Both are used for recover faster. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| Rapamycin (Sirolimus) | SGLT2 Inhibitors (Empagliflozin / Canagliflozin) | |
|---|---|---|
| Human evidence | ★★★★★ | ★★★★☆ |
| Legal status | Off-Label, FDA Approved | FDA Approved, Off-Label |
| How it works | Binds FKBP12 to inhibit mTOR complex 1 — flipping cells from growth to maintenance (autophagy, stress resistance, less senescence). What mTOR is and why dialling it down matters → the mTOR pathway. The compound-specific nuance is… | Block renal glucose reabsorption transporter SLC5A2 (SGLT2), causing urinary glucose loss, mild caloric deficit, ketone elevation, and reduced senescence/inflammation markers. Canagliflozin extended male-mouse lifespan (ITP). |
| In plain English | Rapamycin dials the "grow" switch (mTOR) down periodically, flipping cells into "clean and repair." It extends lifespan in every animal tested — the single most reliable longevity drug — but human data is still coming in. Taken weekly, not… | Makes you pee out excess sugar, creating a gentle calorie deficit and metabolic-stress benefit. Strong heart and kidney data; emerging longevity signal. |
| Bottom line | The most compelling longevity drug we have; still needs human RCTs (PEARL, others ongoing). | Strong cardiometabolic evidence; increasingly used off-label for aging. |
| Availability | Prescription only | Prescription only |
Which is better for recover faster?
Rapamycin (Sirolimus) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
Full breakdowns: Rapamycin (Sirolimus) · SGLT2 Inhibitors (Empagliflozin / Canagliflozin).
Common questions
Is Rapamycin (Sirolimus) or SGLT2 Inhibitors (Empagliflozin / Canagliflozin) better for recover faster?
Rapamycin (Sirolimus) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
What's the difference between Rapamycin (Sirolimus) and SGLT2 Inhibitors (Empagliflozin / Canagliflozin)?
Rapamycin (Sirolimus): The most compelling longevity drug we have; still needs human RCTs (PEARL, others ongoing). — SGLT2 Inhibitors (Empagliflozin / Canagliflozin): Strong cardiometabolic evidence; increasingly used off-label for aging.